SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway.

SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway.
复制标题

DOI:
10.1016/j.canlet.2012.02.035
复制
发表时间:
2012-09-28
期刊:
影响因子:
9.7
通讯作者:
Wang, Zheng
Wang, Zheng
中科院分区:
医学1区
文献类型:
--
作者:
Li, Xuqi;Ma, Qingyong;Xu, Qinhong;Liu, Han;Lei, Jianjun;Duan, Wanxing;Bhat, Kruttika;Wang, Fengfei;Wu, Erxi;Wang, Zheng

文献摘要

参考文献

被引文献

相似文献

在我们之前的研究中,我们发现阻断SDF-1/CXCR 4信号通路可以抑制胰腺癌细胞的体外迁移和侵袭。然而,SDF-1/CXCR 4介导的侵袭的下游调控机制仍不清楚。本文报道了SDF-1/CXCR 4在胰腺癌中的作用以及SDF-1/CXCR 4介导胰腺癌侵袭的可能机制。我们发现,在胰腺癌中,SDF-1/CXCR 4轴与非经典Hedgehog(Hh)通路之间存在串扰。此外,我们的数据表明,CXCR 4的配体,SDF-1诱导CXCR 4阳性胰腺癌侵袭,上皮间质转化(EMT)过程,并激活非经典Hh通路。此外,我们还证明了Smoothened(SMO)抑制剂cyclopamine和Gli-1特异性siRNA可有效抑制由SDF-1/CXCR 4轴激活引起的胰腺癌侵袭和EMT。总的来说,这些数据表明,SDF-1/CXCR 4通过以配体非依赖性方式增加SMO的转录来调节非经典Hh途径。综上所述,SDF-1/CXCR 4轴可能代表了预防胰腺癌进展的有希望的治疗靶点。
In our previous study, we found that blockade of SDF-1/CXCR4 signaling inhibits pancreatic cancer cell migration and invasion in vitro. However, the mechanism governing the downstream regulation of SDF-1/CXCR4-mediated invasion remains unclear. Here we report the role of SDF-1/CXCR4 in pancreatic cancer and the possible mechanism of SDF-1/CXCR4-mediated pancreatic cancer invasion. We show that there is a cross-talk between SDF-1/CXCR4 axis and non-canonical Hedgehog (Hh) pathway in pancreatic cancer. Furthermore, our data demonstrate that the ligand of CXCR4, SDF-1 induces CXCR4-positive pancreatic cancer invasion, epithelial–mesenchymal transition (EMT) process and activates the non-canonical Hh pathway. Moreover, we also demonstrate that the invasion of a pancreatic cancer and EMT resulting from the activation of SDF-1/CXCR4 axis is effectively inhibited by Smoothened (SMO) inhibitor cyclopamine and siRNA specific to Gli-1. Collectively, these data demonstrate that SDF-1/CXCR4 modulates the non-canonical Hh pathway by increasing the transcription of SMO in a ligand-independent manner. Taken together, SDF-1/CXCR4 axis may represent a promising therapeutic target to prevent pancreatic cancer progression.
DOI: 10.1158/0008-5472.can-04-1343
发表时间: 2004-11-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Marchesi, F;Monti, P;Allavena, P
通讯作者: Allavena, P
DOI: 10.1007/s12029-007-0011-7
发表时间: 2006-12-01
影响因子: 1.6
作者:
Billadeau, Daniel D.;Chatterjee, Subrha;Urrutia, Raul
通讯作者: Urrutia, Raul
DOI: 10.1038/nature02009
发表时间: 2003-10-23
期刊: NATURE
影响因子: 64.8
作者:
Thayer, SP;di Magliano, MP;Hebrok, M
通讯作者: Hebrok, M
DOI: 10.1159/000236012
发表时间: 2010-01-01
期刊: PANCREATOLOGY
影响因子: 3.6
作者:
Gao, Zhenjun;Wang, Xingpeng;Hu, Guoyong
通讯作者: Hu, Guoyong
DOI: 10.1007/s10555-010-9256-x
发表时间: 2010-12
影响因子: 9.2
作者:
Sun, Xueqing;Cheng, Guangcun;Hao, Mingang;Zheng, Jianghua;Zhou, Xiaoming;Zhang, Jian;Taichman, Russell S.;Pienta, Kenneth J.;Wang, Jianhua
通讯作者: Wang, Jianhua